These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 36963335)
21. Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration. Yao Y; Chen H; Lou M; Chen T Front Genet; 2023; 14():1071694. PubMed ID: 36755576 [No Abstract] [Full Text] [Related]
22. A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma. Zhang W; Wang H; Wang W; Xue H; Qiao M; Song L; Wang S; Ren Z; Ma Z Anal Cell Pathol (Amst); 2022; 2022():4673514. PubMed ID: 36588797 [TBL] [Abstract][Full Text] [Related]
23. Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma. Tian X; Zhu S; Liu W; Wu X; Wei G; Zhang J; Anwaier A; Chen C; Ye S; Che X; Xu W; Qu Y; Zhang H; Ye D J Cancer Res Clin Oncol; 2023 Dec; 149(19):17451-17466. PubMed ID: 37889309 [TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma. Shen J; Wang L; Bi J BMC Cancer; 2023 Feb; 23(1):160. PubMed ID: 36797708 [TBL] [Abstract][Full Text] [Related]
25. The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma. Lei G; Tang L; Yu Y; Bian W; Yu L; Zhou J; Li Y; Wang Y; Du J Biomed Pharmacother; 2023 Nov; 167():115522. PubMed ID: 37757497 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma. Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P Front Immunol; 2022; 13():948042. PubMed ID: 36275737 [TBL] [Abstract][Full Text] [Related]
27. Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma. Liu A; Li Y; Shen L; Li N; Zhao Y; Shen L; Li Z Front Genet; 2022; 13():983445. PubMed ID: 36338990 [TBL] [Abstract][Full Text] [Related]
28. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties. Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X Front Immunol; 2023; 14():1191365. PubMed ID: 37426638 [TBL] [Abstract][Full Text] [Related]
29. Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma. Zhou L; Luo Z; Li Z; Huang Q Aging (Albany NY); 2020 Jul; 12(14):14620-14632. PubMed ID: 32681792 [TBL] [Abstract][Full Text] [Related]
30. Exploration of the role of Cuproptosis genes and their related long non-coding RNA in clear cell renal cell carcinoma: a comprehensive bioinformatics study. Xia D; Liu Q; Jiao W; Peng L; Wang Q; Tuo Z; Bi L BMC Cancer; 2022 Nov; 22(1):1141. PubMed ID: 36335291 [TBL] [Abstract][Full Text] [Related]
31. Pan-cancer analysis of cuproptosis-promoting gene signature from multiple perspectives. Ma J; Gong B; Zhao Q Clin Exp Med; 2023 Dec; 23(8):4997-5014. PubMed ID: 37318649 [TBL] [Abstract][Full Text] [Related]
32. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature. Chen W; Lin W; Wu L; Xu A; Liu C; Huang P Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523 [No Abstract] [Full Text] [Related]
33. Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment. Xie M; Cheng B; Yu S; He Y; Cao Y; Zhou T; Han K; Dai R; Wang R Cells; 2022 Dec; 12(1):. PubMed ID: 36611966 [TBL] [Abstract][Full Text] [Related]
34. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma. Bian Z; Fan R; Xie L Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236 [TBL] [Abstract][Full Text] [Related]
35. Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8 Gao H; Sun H; He A; Liu H; Zhang Z; Li D; Mao W; Qian J Eur J Med Res; 2024 Jan; 29(1):89. PubMed ID: 38291496 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma. Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983 [TBL] [Abstract][Full Text] [Related]
37. Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma. Wu J; Wang S; Liu Y; Zhang T; Wang X; Miao C Front Immunol; 2023; 14():1132661. PubMed ID: 37350959 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer. Song S; Zhang M; Xie P; Wang S; Wang Y Front Immunol; 2022; 13():978909. PubMed ID: 36341328 [TBL] [Abstract][Full Text] [Related]
39. Single-cell landscape and spatial transcriptomic analysis reveals macrophage infiltration and glycolytic metabolism in kidney renal clear cell carcinoma. Wen CY; Hsiao JH; Tzeng YT; Chang R; Tsang YL; Kuo CH; Li CJ Aging (Albany NY); 2023 Oct; 15(20):11298-11312. PubMed ID: 37847178 [TBL] [Abstract][Full Text] [Related]
40. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Qin Y; Liu Y; Xiang X; Long X; Chen Z; Huang X; Yang J; Li W Mol Cancer; 2023 Mar; 22(1):59. PubMed ID: 36959665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]